CRISPR cuts disease course short in blood disorders
2021
Gene editing for sickle cell disease and β-thalassemia results in potential curative response.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
1
References
0
Citations
NaN
KQI